Company Filing History:
Years Active: 1995
Title: The Innovations of Steven J Mitan
Introduction
Steven J Mitan is an accomplished inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds that target specific receptors in the body. His work has implications for treating various gastrointestinal and central nervous system disorders.
Latest Patents
Mitan holds a patent for "Pyrazolidinone CCK and gastrin antagonists and pharmaceutical." This patent describes novel substituted pyrazolidinones that exhibit significant binding to cholecystokinin (CCK) receptors and gastrin receptors in the brain and peripheral sites such as the pancreas, stomach, and ileum. The pyrazolidinones serve as CCK and gastrin receptor antagonists, finding therapeutic applications in treating gastrointestinal disorders, central nervous system disorders, and appetite regulation in warm-blooded vertebrates. The patent outlines pharmaceutical formulations for these indications.
Career Highlights
Steven J Mitan is associated with Eli Lilly and Company, a leading pharmaceutical firm known for its innovative research and development. His work at Eli Lilly has allowed him to contribute to significant advancements in drug development and therapeutic applications.
Collaborations
Mitan has collaborated with notable colleagues, including Beverley Greenwood and David R Helton. These collaborations have fostered a productive environment for innovation and research within the pharmaceutical sector.
Conclusion
Steven J Mitan's contributions to the field of pharmaceuticals, particularly through his patent on pyrazolidinone compounds, highlight his role as an influential inventor. His work continues to pave the way for advancements in treating various medical conditions.